光学一致性断层扫描血管扫描健康人的血管密度,伪皮综合征和皮性玻璃眼:诊断准确性和与结构参数的关系
Asma Khallouli1, Zeineb Kallel1, Maroua Anane1
1Department of Ophthalmology, Military Hospital of Tunis, Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia.
Journal of current ophthalmology
|October 3, 2025
概括
环囊血管密度 (cpVD) 对于诊断伪皮性玻璃眼 (GEX) 是至关重要的. 显著的周围毛囊微血管损失,即使有保存的结构,也强烈地表明了GEX.
科学领域:
- 眼科医生 眼科 眼科
- 玻璃眼研究研究 玻璃眼研究
- 眼睛成像眼睛成像
背景情况:
- 伪皮综合征 (PEX) 和伪皮性玻璃眼 (GEX) 是二次玻璃眼的常见原因.
- 准确的诊断和PEX和GEX之间的区别对于及时干预至关重要.
- 了解结构和血管变化之间的关系是改善诊断方法的关键.
研究的目的:
- 评估结构和血管测量的诊断准确性.
- 确定PEX和GEX中的结构和血管参数之间的关系.
- 确定关键的成像生物标志物,以区分PEX和GEX.
主要方法:
- 一项观察性病例对照研究,涉及83名个体 (健康,PEX,GEX) 的153只眼睛.
- 结构参数 (GCC,RNFL) 用光谱域光学连贯性断层扫描 (OCT) 进行测量.
- 血管参数 (血管密度) 通过OCT-血管学 (OCT-A) 评估在乳头和黄斑区域.
主要成果:
- 与对照组相比,GEX和PEX组观察到乳头和黄斑血管密度的显著下降.
- 在环囊血管密度 (cpVD) 和RNFL之间发现了强烈的相关性,以及在表面状血管密度和GCC之间.
- cpVD在区分PEX和GEX方面表现出最高的诊断值 (AUC = 0.958).
结论:
- 环囊血管密度 (cpVD) 是诊断伪皮性玻璃眼 (GEX) 的关键指标.
- 即使保留了视网膜结构,也显著地丧失了周围毛囊微血管,强烈地表明了GEX.
- OCT血管学参数,特别是cpVD,为GEX提供了宝贵的诊断见解.
更多相关视频
相关概念视频
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Imaging Studies VII: Vascular Imaging
DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...


